Published in Ann Oncol on February 21, 2012
Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein. Br J Cancer (2013) 0.87
Small cell carcinoma of the uterine cervix in pregnancy: A case report and review of the literature. Oncol Lett (2014) 0.79
Cisplatin inhibits hippocampal cell proliferation and alters the expression of apoptotic genes. Neurotox Res (2013) 0.79
Adjuvant chemotherapy for early-stage cervical cancer. Chin J Cancer Res (2016) 0.77
Efficacy of concurrent single-agent chemotherapy using radiotherapy in patients with cervical cancer: a meta-analysis. Int J Clin Exp Med (2015) 0.76
Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy. BMC Cancer (2017) 0.75
Treatment-interval associated effect of irradiation on locoregionally-relapsed ovarian cancer. Mol Clin Oncol (2014) 0.75
A comparative dosimetric study of volumetric-modulated arc therapy vs. fixed field intensity-modulated radiotherapy in postoperative irradiation of stage IB-IIA high-risk cervical cancer. Oncol Lett (2015) 0.75
Effects of chemotherapy on patients with recurrent cervical cancer previously treated with concurrent chemoradiotherapy: a retrospective multicenter survey in Japan. Int J Clin Oncol (2014) 0.75
Sequences at the somatic recombination sites of immunoglobulin light-chain genes. Nature (1979) 11.83
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet (2003) 8.88
An improved algorithm for nucleic acid secondary structure display. Comput Appl Biosci (1988) 5.91
Plasmids designed to alter the antibiotic resistance expressed by insertion mutations in Bacillus subtilis, through in vivo recombination. Gene (1994) 3.82
On two-dimensional passive random walk in lipid bilayers and fluid pathways in biomembranes. J Membr Biol (1979) 3.37
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol (2000) 3.09
Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis (2006) 2.99
Easy cloning of mini-Tn10 insertions from the Bacillus subtilis chromosome. J Bacteriol (1994) 2.53
Correction of satellite imagery over mountainous terrain. Appl Opt (1998) 2.46
Antenatal microbiologic and maternal risk factors associated with prematurity. Am J Obstet Gynecol (1990) 2.44
Improving classroom behavior in mentally retarded children through correspondence training. J Appl Behav Anal (1982) 2.39
Somatic mutation creates diversity in the major group of mouse immunoglobulin kappa light chains. J Exp Med (1984) 2.33
The process of metastasisation for breast cancer. Eur J Cancer (2003) 2.30
Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol (2003) 2.22
Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem (1986) 2.22
Induction of levansucrase in Bacillus subtilis: an antitermination mechanism negatively controlled by the phosphotransferase system. J Bacteriol (1990) 2.21
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. Ann Oncol (2005) 1.89
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet (1995) 1.84
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer (2002) 1.77
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72
Overcoming language difficulties with migrant patients. Med J Aust (1979) 1.72
Central and peripheral thermal control of effectors in homeothermic temperature regulation. Physiol Rev (1986) 1.71
Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett (2003) 1.70
Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J Clin Endocrinol Metab (1985) 1.69
Molecular characterization of cyanophycin synthetase, the enzyme catalyzing the biosynthesis of the cyanobacterial reserve material multi-L-arginyl-poly-L-aspartate (cyanophycin). Eur J Biochem (1998) 1.65
Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast-feeding. Int J Obes Relat Metab Disord (2003) 1.62
Excimer-forming lipids in membrane research. Chem Phys Lipids (1980) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol (2010) 1.59
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev (1995) 1.59
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res (2001) 1.59
New therapeutic application of the fiberoptic bronchoscope. Chest (1977) 1.54
Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry. Gynecol Oncol (1998) 1.49
Temperature regulation: the spinal cord as a site of extrahypothalamic thermoregulatory functions. Rev Physiol Biochem Pharmacol (1974) 1.48
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.48
Breast reconstruction with latissimus dorsi flap: improved aesthetic results after transection of its humeral insertion. Plast Reconstr Surg (1999) 1.46
Gene encoding parathyroid hormone. Nucleotide sequence of the rat gene and deduced amino acid sequence of rat preproparathyroid hormone. J Biol Chem (1984) 1.45
Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes (2006) 1.45
p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999) 1.45
Continuous growth of mitogen-reactive B lymphocytes. Scand J Immunol (1975) 1.43
Surgical intervention in relapsed ovarian cancer is beneficial: pro. Ann Oncol (2013) 1.42
Laparoscopic lymphocele fenestration in gynaecological cancer patients after retroperitoneal lymph node dissection as a first-line treatment option. BJOG (2013) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Neurocognitive testing in late-onset Tay-Sachs disease: a pilot study. J Inherit Metab Dis (2008) 1.39
[Mucocele of the appendix as a rare differential diagnosis of adnexa tumor]. Zentralbl Gynakol (1994) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinum. Onkologie (2004) 1.39
Tl(2)CO(3) at 3.56 GPa. Acta Crystallogr C (2008) 1.38
Nitroglycerin to facilitate fetal extraction during cesarean delivery. Obstet Gynecol (1998) 1.38
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene (2007) 1.37
Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study. Gynecol Oncol (2006) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Glucagon gene sequence. Four of six exons encode separate functional domains of rat pre-proglucagon. J Biol Chem (1984) 1.34
Optical imaging in drug discovery and diagnostic applications. Adv Drug Deliv Rev (2005) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol (1990) 1.30
Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol (2000) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol (1995) 1.27
[Cardiotocographic diagnosis of fetal hazard using a CTG-score]. Gynakol Rundsch (1974) 1.27
Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet (1999) 1.26
Sensory transmission of spinal heat and cold sensitivity in ascending spinal neurons. Pflugers Arch (1971) 1.25
Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J (1989) 1.25
Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer (2001) 1.23
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. Ann Oncol (2007) 1.22
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Binding of polylysine to charged bilayer membranes: molecular organization of a lipid.peptide complex. Biochim Biophys Acta (1978) 1.17
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol (2007) 1.16
Activation and activation-driven death of human gamma/delta T cells. Immunol Rev (1991) 1.16
Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect Immun (2005) 1.16
Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer (2007) 1.15
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy. Ann Oncol (2012) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
[Detection of staphylococcus enterotoxin B using the ELISA test]. Zentralbl Veterinarmed B (1977) 1.13
p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res (1998) 1.13
Human pituitary gonadotropin index. I. Standardized LRH test criteria for evaluation of functional amenorrhea. J Clin Endocrinol Metab (1975) 1.12
Formulation of amphotericin B as nanosuspension for oral administration. Int J Pharm (2003) 1.12
Effect of thermal stimulation of spinal cord on respiratory and cortical activity. Am J Physiol (1969) 1.12
Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod (2002) 1.11
FasL:Fas ratio--a prognostic factor in breast carcinomas. Cancer Res (2000) 1.10
Spinal cord and hypothalamus as core sensors of temperature in the conscious dog. 3. Identity of functions. Pflugers Arch (1971) 1.09
CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Ther (2003) 1.09
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort. Br J Cancer (2011) 1.09
Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765). Breast Cancer Res Treat (2010) 1.08
Cancer in pregnancy: maternal-fetal conflict. J Cancer Res Clin Oncol (2003) 1.08
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma. J Pathol (2008) 1.07
Pre-proglucagon messenger ribonucleic acid: nucleotide and encoded amino acid sequences of the rat pancreatic complementary deoxyribonucleic acid. Endocrinology (1984) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Intra-abdominal thermosensitivity in the rabbit as compared with spinal thermosensitivity. Pflugers Arch (1973) 1.07
Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients. J Surg Oncol (2010) 1.06
Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth (2012) 1.06
Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol (2001) 1.05
Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Support Care Cancer (1998) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Genital tuberculosis as the cause of tuboovarian abscess in an immunosuppressed patient. Infect Dis Obstet Gynecol (2010) 1.04
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer (2000) 1.04